ZF

Zeba Farheen Khateeb

Active Director Director DIN 10274929
DIN 10274929 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Zeba Farheen Khateeb

Data last updated:

Zeba Farheen Khateeb is a Director at Raizams Pharma Private Limited (since 2023). Raizams Pharma Private Limited reported revenue of ₹2.8 Lakh (FY 2024).

DIN 10274929
Primary Designation Director
First Appointment 10 Aug 2023
Oldest Company Age 3 yrs
Largest company Raizams Pharma Private Limited · ₹2.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raizams Pharma Private Limited U46497MH2023PTC408456
Director10 Aug 20232023₹2.8 Lakh (FY 2024)Active

Board colleagues of Zeba Farheen Khateeb

NameDINCompanyDesignation
Mohammad Rayyan Merajuddin10986800Raizams Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Raizams Pharma Private Limited
Premium access

Shareholding and investment profile for Zeba Farheen Khateeb

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zeba Farheen Khateeb

Zeba Farheen Khateeb currently holds 1 directorship: Raizams Pharma Private Limited (Director, since 10 Aug 2023, revenue ₹2.8 Lakh (FY 2024)).

Zeba Farheen Khateeb was first appointed on 10 Aug 2023 as Director at Raizams Pharma Private Limited.

The current boards of Zeba Farheen Khateeb's companies include Mohammad Rayyan Merajuddin (Raizams Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available